ST

Sivarajan Thiruganasambandam Chettiar

Active Director Additional Director DIN 09203754
DIN 09203754 First appointment Jun 2021 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jun 2021
Shareholding value •••• Premium profile

About Sivarajan Thiruganasambandam Chettiar

Data last updated:

Sivarajan Thiruganasambandam Chettiar is an Additional Director at Archeron Clinical Solutions Private Limited (since 2021), Director at Inovio Clinical Trials Private Limited (since 2021) and Director at Archeron Innovation Private Limited (since 2022). The companies operate in Business Services, Healthcare and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹3.1 Lakh; the largest is Archeron Clinical Solutions Private Limited at ₹1.8 Lakh (FY 2021). Earlier, Sivarajan Thiruganasambandam Chettiar was an Additional Director at Aksharam Infratech Private Limited (2021–2022) and Director at Vihin Trading Services Private Limited (2021).

DIN 09203754
Primary Designation Additional Director
Industry Business Services
First Appointment 16 Jun 2021
Oldest Company Age 7 yrs
Largest company Archeron Clinical Solutions Private Limited · ₹1.8 Lakh (FY 2021)
Combined revenue ₹3.1 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director25 Aug 20212019₹1.8 Lakh (FY 2021)Active
Director25 Nov 20212019₹1.4 Lakh (FY 2021)Active
Archeron Innovation Private Limited U72900KA2022PTC156707
Director17 Jan 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aksharam Infratech Private Limited U74999DL2019PTC344910
Additional Director28 Nov 20212019₹5.1 Lakh (FY 2020)Active
Director16 Jun 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sivarajan Thiruganasambandam Chettiar

Directorship timeline

Open interactive timeline →
Archeron Innovation Private Limited
Inovio Clinical Trials Private Limited
Archeron Clinical Solutions Private Limited
Aksharam Infratech Private Limited
Premium access

Shareholding and investment profile for Sivarajan Thiruganasambandam Chettiar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivarajan Thiruganasambandam Chettiar

Sivarajan Thiruganasambandam Chettiar currently holds 3 directorships: Archeron Clinical Solutions Private Limited (Additional Director, since 25 Aug 2021, revenue ₹1.8 Lakh (FY 2021)); Inovio Clinical Trials Private Limited (Director, since 25 Nov 2021, revenue ₹1.4 Lakh (FY 2021)); Archeron Innovation Private Limited (Director, since 17 Jan 2022).

Sivarajan Thiruganasambandam Chettiar was first appointed on 16 Jun 2021 as Director at Vihin Trading Services Private Limited. The most recent appointment on record is 17 Jan 2022 at Archeron Innovation Private Limited.

The 2 current companies of Sivarajan Thiruganasambandam Chettiar that report revenue have a combined latest revenue of ₹3.1 Lakh: Archeron Clinical Solutions Private Limited ₹1.8 Lakh (FY 2021); Inovio Clinical Trials Private Limited ₹1.4 Lakh (FY 2021).

Sivarajan Thiruganasambandam Chettiar held 2 earlier board appointments: Aksharam Infratech Private Limited (Additional Director, 28 Nov 2021 to 30 Sep 2022); Vihin Trading Services Private Limited (Director, 16 Jun 2021 to 24 Sep 2021).

The current boards of Sivarajan Thiruganasambandam Chettiar's companies include Soumendra Nath Ray (Archeron Clinical Solutions Private Limited), Siddhant Sharma (Archeron Innovation Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available